Med-tech Companies to Face New Pressures in China

Dow Jones07-15

0750 GMT - Suppliers of medical equipment look set to face new pricing headwinds in China after the country's National Health Commission set out plans for centralized procurement of radiotherapy, imaging and surgical tools, Citi analysts say in a research note. "This development raises further questions about the longer-term revenue and profitability potential of the Chinese market" across the med-tech sector, the analysts say. Among European med-tech companies, Sweden's Elekta and Germany's Siemens Healthineers seem the most exposed, according to Citi. Dutch peer Royal Philips doesn't compete in radio-oncology or positron emission tomography, but it is already seeing pressure through centralized procurement of ultrasound equipment, the analysts say. Shares in Elekta and Healthineers fall 1.4% and 1%, respectively, while Philips is up 0.5%. (adria.calatayud@wsj.com)

(END) Dow Jones Newswires

July 15, 2026 03:51 ET (07:51 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2651045891?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-15 15:51","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2651045891","market":"nz","top_or_hot":-1,"title":"Med-tech Companies to Face New Pressures in China","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0750 GMT - Suppliers of medical equipment look set to face new pricing headwinds in China after the country's National Health Commission set out plans for centralized procurement of radiotherapy, imaging and surgical tools, Citi analysts say in a research note. \"This development raises further questions about the longer-term revenue and profitability potential of the Chinese market\" across the med-tech sector, the analysts say. Among European med-tech companies, Sweden's Elekta and Germany's Siemens Healthineers seem the most exposed, according to Citi. Dutch peer Royal Philips doesn't compete in radio-oncology or positron emission tomography, but it is already seeing pressure through centralized procurement of ultrasound equipment, the analysts say. Shares in Elekta and Healthineers fall 1.4% and 1%, respectively, while Philips is up 0.5%. (adria.calatayud@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 15, 2026 03:51 ET (07:51 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Med-tech Companies to Face New Pressures in China</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMed-tech Companies to Face New Pressures in China\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-07-15 15:51</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0750 GMT - Suppliers of medical equipment look set to face new pricing headwinds in China after the country's National Health Commission set out plans for centralized procurement of radiotherapy, imaging and surgical tools, Citi analysts say in a research note. \"This development raises further questions about the longer-term revenue and profitability potential of the Chinese market\" across the med-tech sector, the analysts say. Among European med-tech companies, Sweden's Elekta and Germany's Siemens Healthineers seem the most exposed, according to Citi. Dutch peer Royal Philips doesn't compete in radio-oncology or positron emission tomography, but it is already seeing pressure through centralized procurement of ultrasound equipment, the analysts say. Shares in Elekta and Healthineers fall 1.4% and 1%, respectively, while Philips is up 0.5%. (adria.calatayud@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 15, 2026 03:51 ET (07:51 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PHG","symbol_name":"飞利浦","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2651045891","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2651045891","pubTimestamp":1784101860,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"0750 GMT - Suppliers of medical equipment look set to face new pricing headwinds in China after the country's National Health Commission set out plans for centralized procurement of radiotherapy, imaging and surgical tools, Citi analysts say in a research note. \"This development raises further questions about the longer-term revenue and profitability potential of the Chinese market\" across the med-tech sector, the analysts say. Among European med-tech companies, Sweden's Elekta and Germany's Siemens Healthineers seem the most exposed, according to Citi. Dutch peer Royal Philips doesn't compete in radio-oncology or positron emission tomography, but it is already seeing pressure through centralized procurement of ultrasound equipment, the analysts say. Shares in Elekta and Healthineers fall 1.4% and 1%, respectively, while Philips is up 0.5%.  Dow Jones NewswiresJuly 15, 2026 03:51 ET Copyright  2026 Dow Jones & Company, Inc.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"PHG":"飞利浦","BK4588":"碎股","BK4585":"ETF&股票定投概念","BK4082":"医疗保健设备"},"translate_title":"医疗科技公司在中国面临新压力","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PHG":0.9},"content_text":"0750 GMT - Suppliers of medical equipment look set to face new pricing headwinds in China after the country's National Health Commission set out plans for centralized procurement of radiotherapy, imaging and surgical tools, Citi analysts say in a research note. \"This development raises further questions about the longer-term revenue and profitability potential of the Chinese market\" across the med-tech sector, the analysts say. Among European med-tech companies, Sweden's Elekta and Germany's Siemens Healthineers seem the most exposed, according to Citi. Dutch peer Royal Philips doesn't compete in radio-oncology or positron emission tomography, but it is already seeing pressure through centralized procurement of ultrasound equipment, the analysts say. Shares in Elekta and Healthineers fall 1.4% and 1%, respectively, while Philips is up 0.5%. (adria.calatayud@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  July 15, 2026 03:51 ET (07:51 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2651045891","isCrawlerRequest":true}